IgG anti-β2 glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: Prevalence and clinical correlations

Clinical Rheumatology

Volumn 21, Issue 5, 2002, Pages 382-385

  Ong, S G ^a   Cheng, H M ^a   Soon, S C ^a   Goh, E ^a   Chow, S K ^a   Yeap, S S ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Anti 2 glycoprotein I antibody; Anticardiolipin antibody; Antiphospholipid syndrome; Malaysia; Systemic lupus erythematosus

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; DEEP VEIN THROMBOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INCIDENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALAYSIA; MALE; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANALYSIS OF VARIANCE; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALAYSIA; MALE; MIDDLE AGED; PREVALENCE; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 0036741999     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670200102     Document Type: Article

References (26)

1. Harris EN. Antiphospholipid syndrome. In: Klippel JH, Dieppe PA, eds. Rheumatology, Vol. 2. London: Mosby, 1998:7.35.1-7.35.6.
2. McNeil HP, Simpson RJ Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
3. Galli M, Comfurius P, Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but a plasma cofactor. Lancet 1990;335:1544-7.
4. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of auto-immune disease. Lancet 1990;336:177-8.
5. Hunt JE, McNeil HP, Morgan GJ Crameri RM, Krilis SA. A phospholipid-β2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992;1:75-81.
6. Martinuzzo ME, Forastiero RR, Carreras LO. Anti β2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995;89:397-407.
7. Balestrieri G, Tincani A, Spatola L et al. Anti beta2-glycoprotein I antibodies: A marker of antiphospholipid syndrome? Lupus 1995;4:122-30.
8. Teixido M, Font J Reverter JC et al. Anti beta2 glycoprotein I antibodies: A useful marker for the antiphospholipid syndrome. Br J Rheumatol 1997;36:113-16.
9. Tsutsumi A, Matsuura E, Ichikawa K et al. Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:1466-74.
10. Tan EM, Cohen AS, Fries JT et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
11. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999;42:1309-11.
12. Toschi V, Motta A, Castelli C et al. Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosus. Haemostasis 1993;23:275 83.
13. Derksen RH, Hasselaar P, Blokzjil L, Gmelig Meyling FH, De Groot PG. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients. Ann Rheum Dis 1988;47:364-7.
14. Fort JG, Cowchock FS, Abruzzo JL, Smith JB. Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 1987;30;752-60.
15. Kalunian KC, Peter JD, Middlekauff HR et al. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 1988;85:602-8.
16. Jones HW, Ireland R, Senaldi G et aL Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus. Ann Rheum Dis 1991;50:173-5.
17. Alarcon-Segovia D, Deleze M, Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective study of 500 consecutive patients. Medicine (Baltimore) 1989;68:353-65.
18. Ikeda Y. Clinical significance of phospholipid-dependent anti-β2-glycoprotein I antibodies in systemic lupus erythematosus. Lupus 1995; 4:472-6.
19. Fanopoulos D, Teodorescu MR, Varga J, Teodorescu M. High frequency of abnormal levels of IgA anti-β2-glycoprotein I antibodies in patients with SLE: relationship with antiphospholipid syndrome. J Rheumatol 1998; 25:675-80.
20. Viard JP, Amoura Z, Bach JF. Association of anti-β2-glycoprotein I antibodies with lupus-type circulating anti-coagulant and thrombosis in SLE. Am J Med 1992; 93:181-6.
21. Tsutsumi A, Ichikawa K, Matsuura E, Koike K. Anti-beta2-glycoprotein I antibodies. Lupus 1998; 7 Suppl 2:S98-102.
22. Tubach F, Hayem G, Marchand J-L et al. IgG anti-β2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome. J Rheumatol 2000; 27:1437-43.
23. El-Kadi HS, Keil LB, DeBari VA. Analytical clinical relationships between human IgG autoantibodies to β-glycoprotein I and anticardiolipin antibodies. J Rheumatol 1995; 22:2233-7.
24. McNally T, Makie IJ, Machin SJ Isenberg DA. Increased levels of β2-glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. Br J Rheumatol 1995; 34:1031-6.
25. Out HJ, van Vliet M, de Groot PG, Derksen RH. Prospective study of fluctuations of lupus anticoagulant activity and anti-cardiolipin antibodies titre in patients with systemic lupus erythematosus. Ann Rheum Dis 1992; 51:353-7.
26. Inanc M, Donohoe S, Ravirajan CT et al. Anti-β2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol 1998; 37:1089-94.